Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2001Antimicrobial Agents and ChemotherapyOpen Access

In Vitro and In Vivo Activities of Amikacin, Cefepime, Amikacin plus Cefepime, and Imipenem against an SHV-5 Extended-Spectrum β-Lactamase-ProducingKlebsiella pneumoniaeStrain

View Full Paper
Ask AI
Bookmark
Share

Authors

DSDóra SzabóSemmelweis UniversityAMAndrás MáthéJahn Ferenc Dél-Pesti Kórház és RendelőintézetZFZsolt FiletóthNational Institute of Traumatology & Orthopaedic Rehabilitation

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Szabó et al. (2001) studied this question.

synapsesocial.com/papers/6a6f91d535aa2c282ce0eba3https://doi.org/10.1128/aac.45.4.1287-1291.2001
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients1987 · 34 citations
  2. 2Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant1992 · 45 citations
  3. 3Molecular Epidemiology of a Cluster of Cases Due to <i>Klebsiella pneumoniae</i> Producing SHV-5 Extended-Spectrum β-Lactamase in the Premature Intensive Care Unit of a Hungarian Hospital1999 · 46 citations
  4. 4Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model1988 · 728 citations